Close
ACHEMA MIDDLE EAST 2026

UCB showcases new research and continued epilepsy leadership at the 2017 American Epilepsy Society Annual Meeting

UCB is pleased to announce that 25 scientific abstracts have been accepted for poster presentation at the upcoming 71st American Epilepsy Society (AES) Annual...

PureTech’s Vedanta Biosciences expands clinical, translational collaborations in cancer immunotherapy

PureTech Health plc, an advanced, clinical-stage biopharmaceutical company, announced that Vedanta Biosciences, an affiliate of PureTech Health, has expanded its international network of clinical,...

Takeda Pharma begins phase 1 trial of Zika vaccine candidate, TAK-426

Takeda Pharmaceutical Company Limited has announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a phase 1 clinical...

InDex Pharmaceuticals Reports New Mechanism of Action Data for Cobitolimod

InDex Pharmaceuticals Holding AB (publ) today announced new scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate. The findings...

Lilly’s Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis

Eli Lilly and Company announced that the U.S. FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic...

Pfizer Enters Into Agreement To Develop And Commercialize Cresemba® (Isavuconazole) In China And Asia Pacific Region

Pfizer Inc and Basilea Pharmaceutica Ltd , an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced...

Vaccinex And Catalent Biologics To Collaborate On Antibody-Drug Conjugate Development

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Vaccinex, Inc.,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...